Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 348 participants.
Also called NCT05604638
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 348 participants
- Registry
-
NCT05604638
-
- Other papers using this trial's data
- Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT05604638. Randomized; quadruple masking; primary purpose treatment. Start 2024-04-24 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
- Acronym
- INSTANT
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tirofiban Hydrochloride
- Intervention (Drug)
- Placebo
- Lead sponsor
- Second Affiliated Hospital of Guangxi Medical University
- Collaborator
- Ganzhou City People's Hospital
Record details
- Record id
cardio:ct-nct05604638- Content hash
e84aebbf75a1fbfd216b27e06b7c9e47140d684e985b0541ce81bfc4960dc7b0